- Global Pharma News & Resources

The Latex Agglutination Test market to stay “Astute” Amidst Economic Slowdown

The reaction between a specific antibody and antigen results in visible clumping is called agglutination. The test used to analyze the variation on the clumping ability of the antigen when it reacted with an antibody placed on the surface of latex particles is called latex agglutination test. The agglutination reaction may also be reversed, the use of systematic beads provide the advantages and consistency, uniformity, and stability. Moreover, the latex agglutination assay gives rapid advantage for quick results within a shorter period of time. Additionally, latex agglutination test provides the versatility of the reaction, simple design and ability to work in small quantity of the sample. Among the multiple diseases, the test mostly used for the serological diagnosis of rheumatoid arthritis. However, the latex agglutination principle also used in the diagnosis of infections like Hepatitis B, H.influenzae, N. meningitidis, etc.

Latex agglutination test market anticipated growth in the forecast period with rising patent pool suffering from rheumatoid arthritis, anticipated to grow over the forecast period. The effectiveness of the testing outcome is the major driver for the latex agglutination test market. However, the latex agglutination test also applied to the diagnosis of the autoimmune disorder and Hepatitis B infections, since the increasing the Hepatitis B infection to the children’s expected to boost the latex agglutination test market in future. Regional government authorities have more concern to provide the treatment for the infectious disease like hepatitis B. Since, the flexible regional government policies expected to fuel the latex agglutination test market in the future. Rising demand for point-of-care services is expected to drive the latex agglutination test market during the forecast period. Point-of-care services provide accurate results in a shorter period of time compared to traditional methods. Less awareness of the people about the test may restrain the latex agglutination test market in the future. Vaccination program for the infectious disease expected to cause slowdown growth of latex agglutination test system market.

To remain ‘ahead’ of your competitors, request for a sample here@

The global latex agglutination test system market is classified on the basis of test type, product type, disease type, end user and region.

Based test type, Latex Agglutination Test market is segmented into the following:

  • Latex Agglutination Test (LAT) for Antibody Detection
  • Latex Agglutination Test (LAT) for Antigen Detection

Based product type, Latex Agglutination Test market is segmented into the following:

  • Indirect fluorescent antibody test
  • Hemagglutination – inhibition
  • Serum neutralization

Based on end user Latex Agglutination Test market is segmented into the following:

  • Hospitals
  • Diagnostic Centers
  • Specialty clinics

From the test type segment, latex agglutination test for antigen expected to boost the demand of the latex agglutination test market as compared to the latex agglutination test for antibody detection test, Due to the rising prevalence of the opportunistic disease like H. influenza, Streptococcus species etc. based on the product type ELISA is most common test used for the antigen and antibody detection in serological test, over the forecast period ELISA test anticipated to increase in demand for latex agglutination test market in future. Indirect fluorescent antibody test and hemagglutination – inhibition test market may show the slower growth in the latex agglutination test market due to less awareness and popularity among the people. Among the end user market hospitals are expected to show lucrative growth as compared to the diagnostic center for the latex agglutination test market.

To receive extensive list of important regions, Request Methodology here @

Among the regional presence, Geographically, North America anticipated being the leading region globally during the forecast period. The high adoption rate of diagnosis device and the accessibility of advanced techniques for diagnosis are the two major factors for high market share in the region. Europe region expected to show the second dominating market for latex agglutination test, since the increasing demand for the novel diagnostic methods for the infectious diseases and people preferring the invasive techniques for the diagnosis as compared to the traditional methods. Hence, in coming years latex agglutination test may take good stand in Europe region. However, due to the high prevalence of infectious disease rate India and China is the key factor behind the robust the growth of latex agglutination test market in South Asia and East Asia region. The Middle East and Africa are expected to account for being the least lucrative market for latex agglutination test due to lack of technology advancement and good diagnostic methods.

Some of the key players across the value chain of latex agglutination test market are Thermo Fisher Scientific, Biocompare, Biotec, HiMedia Laboratories, bioMérieux SA, Hardy Diagnostics, Microbiology International, Creative Diagnostics, Biotium, BioLegend, Inc.and others.

You Can Request for TOC Here@

Explore Extensive Coverage of PMR`s 

Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –


Editor Details

Last Updated: 20-Oct-2020